Used as a key intermediate in the synthesis of fluorinated quinazoline derivatives, which show potential as pharmaceutical agents. Exhibits activity in kinase inhibition pathways, making it valuable in research for anticancer and anti-inflammatory drug development. Its fluorinated structure enhances metabolic stability and bioavailability in medicinal chemistry applications. Also employed in the design of targeted therapies involving EGFR and VEGFR inhibitors. Commonly utilized in laboratory research for structure-activity relationship (SAR) studies of heterocyclic compounds.